Christopher Lane, MD, PhD
Principal Clinical Director, Neuroscience Product Development at Roche
Chris Lane is a principal clinical director in Product Development, Neuroscience at Roche Products Ltd based in the UK, where he is the clinical science lead for trontinemab.
He has been in neurodegeneration research for more than ten years and was previously a clinical research fellow and practising cognitive neurologist at the Dementia Research Centre, University College London, where he received his PhD. He was awarded his medical degree by Cambridge University and University College London.
Participació
14th May, 2026
Latest results and next development steps for trontinemab in Alzheimer’s disease